Costa Rica vs Portugal: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Costa Rica
99.0%
in 2024
Portugal
99.0%
in 2024
Costa Rica rank
1st
Portugal rank
1st
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Costa Rica
- Portugal
How they compare
Costa Rica currently reports 99.0% against 99.0% in Portugal, a difference of 0.0%.
The two have swapped places 2 times across 27 shared years of data; in 1998 it was Portugal ahead.
Costa Rica ranks 1st and Portugal ranks 1st of 192 countries.
Portugal has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Costa Rica | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 47.0% | 93.0% | 46.0% | Portugal |
| 2000s | 89.1% | 94.4% | 5.3% | Portugal |
| 2010s | 92.2% | 98.0% | 5.8% | Portugal |
| 2020s | 96.4% | 99.0% | 2.6% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Costa Rica or Portugal?
- Costa Rica, at 99.0% against 99.0% in Portugal as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Costa Rica and Portugal?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Portugal?
- 27 years are reported by both, from 1998 to 2024.
- How do Costa Rica and Portugal rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Costa Rica ranks 1st and Portugal ranks 1st of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.